The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors
Financial Services >> CEO Interviews >> September 23, 2013

Interview with the Founder, Chairman and CEO: Alexandria Real Estate Equities, Inc. (ARE)

Marcus, Joel S.
Joel S. Marcus is the Founder, Chairman and Chief Executive Officer of Alexandria Real Estate Equities, Inc., the largest and leading real estate investment trust focused on owning, operating and developing high-quality, sustainable real estate for the broad and diverse life science industry. Mr. Marcus founded the company in 1994 as a garage startup with a business plan and $19 million of seed capital, and has led its growth into a publicly traded, investment-grade REIT with a total market capitalization of approximately $8 billion. Mr. Marcus cofounded and leads Alexandria Venture Investments, the company’s strategic venture arm. Mr. Marcus also cofounded the Alexandria Summit, an annual, invitation-only gathering of the world's foremost to advance the most important health science issues. Prior to founding Alexandria Real Estate Equities, Inc., Mr. Marcus was formerly a practicing Certified Public Accountant and Tax Manager with Arthur Young & Co., focusing on the financing and taxation of REITs. Mr. Marcus serves on the boards of the Accelerator Corporation, Citizens United for Research in Epilepsy, Foundation for the National Institutes of Health, The Hamner Institutes for Health Sciences, Intra-Cellular Therapies, Inc., Multiple Myeloma Research Foundation, the Partnership for New York City and Rexford Industrial Realty, Inc. Mr. Marcus received the Ernst & Young Entrepreneur of the Year Award, Los Angeles — Real Estate. He completed his undergraduate degree and Juris Doctor at the University of California, Los Angeles. Profile
TWST: If you would, please start by introducing readers to the company with a little bit of the history of Alexandria.

Mr. Marcus: Alexandria was started in 1994 as a garage

Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
General Electric Company
Walmart Inc.
International Business Machines Corporation
Citigroup Inc.
Exxon Mobil Corporation
Bank of America Corporation
Dell Inc.
Verizon Communications Inc.
Alphabet Inc

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS
Interview with the CEO: Pasithea Therapeutics Corp. (NASDAQ:KTTA)
Interview with the CEO: BetterLife Pharma Inc. (OTCMKTS:BETRF)
Interview with the CEO: Cansortium Inc. (OTCMKTS:CNTMF)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
AI Opportunities Expand to Industrial, Utilities and Energy Sectors
India Fund Manager Expects Discretionary Spending to Grow
Inefficiency in Ex-US Markets Creates Opportunity to Buy at a Discount
ANALYST INTERVIEWS
Five Companies Dominate in Psychedelics-Based Drug Development
Cidara’s Long-Acting Antiviral Drug Could Be a Game Changer
Spotting Potential in the High-Risk, High Reward Neuroscience Space
Since 1963
© The Wall Street Transcript 2016, 2024
Terms and Conditions
Privacy Policy